RT @alphavestcap: https://t.co/ySPtLCwrTg @cvpayne exposing Wall Street naked shorting . Even $NWBO whose GBM (brain tumor)drug (htt…
https://t.co/ySPtLCwrTg @cvpayne exposing Wall Street naked shorting . Even $NWBO whose GBM (brain tumor)drug (https://t.co/rBBETdOpAA) is dramatically increasing survival . The defendants :https://t.co/GUEmMvwQMr . $nwbo @alphavestcap
RT @rsloftx: 2) GBM BREAKTHROUGH $dcvax #dcvax $nwbo #nwbo @DrMarcSiegel @cvpayne @marthamaccallum Dr Siegel - Check out the Jama Oncolo…
RT @rsloftx: 3) GBM BREAKTHROUGH $dcvax #dcvax $nwbo #nwbo @DrMarcSiegel @cvpayne @marthamaccallum Dr Siegel - Check out the Jama Oncolo…
RT @rsloftx: 2) GBM BREAKTHROUGH $dcvax #dcvax $nwbo #nwbo @DrMarcSiegel @cvpayne @marthamaccallum Dr Siegel - Check out the Jama Oncolo…
RT @rsloftx: 2) GBM BREAKTHROUGH $dcvax #dcvax $nwbo #nwbo @DrMarcSiegel @cvpayne @marthamaccallum Dr Siegel - Check out the Jama Oncolo…
RT @rsloftx: 2) GBM BREAKTHROUGH $dcvax #dcvax $nwbo #nwbo @DrMarcSiegel @cvpayne @marthamaccallum Dr Siegel - Check out the Jama Oncolo…
RT @rsloftx: 3) GBM BREAKTHROUGH $dcvax #dcvax $nwbo #nwbo @DrMarcSiegel @cvpayne @marthamaccallum Dr Siegel - Check out the Jama Oncolo…
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/4ddh5fKcJ0 via @JAMAOnc part of @JAMANetwork - "adding DCVax-L to SOC was associated with a clinically meaningful and statistically significant improvement in m
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @andrewcaravello: @ctrlEntropy @PeterAttiaMD #DCvax-L with PD1 inhibitor for GBM.
RT @andrewcaravello: @ctrlEntropy @PeterAttiaMD #DCvax-L with PD1 inhibitor for GBM.
RT @andrewcaravello: @PeterAttiaMD Hi Peter, what are your thoughts on #DCVax-L (personalized autologous personalized dendritic cell vaccin…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
@ctrlEntropy @PeterAttiaMD #DCvax-L with PD1 inhibitor for GBM.
@PeterAttiaMD Hi Peter, what are your thoughts on #DCVax-L (personalized autologous personalized dendritic cell vaccine technology) $NWBO https://t.co/l9xSDDzp5m https://t.co/GjuLDCODh9
https://t.co/tHFpFn3lYa $nwbo @alphavestcap
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @SeekingTruth4us: @backtolife_2023 After mRNA injections my brother developed stage 4 brain cancer #Glioblastoma with shocking MRIs http…
RT @SeekingTruth4us: @backtolife_2023 After mRNA injections my brother developed stage 4 brain cancer #Glioblastoma with shocking MRIs http…
@backtolife_2023 After mRNA injections my brother developed stage 4 brain cancer #Glioblastoma with shocking MRIs https://t.co/weHWLReYCc latest https://t.co/1m3qo6RB9z 💸DejaVu suppression of repurposed agents🤑 https://t.co/zJEtv9u1YD What they don't te
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @ATLnsider: Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed &…
Dr. Steven Brem is also excited about #DCVax-L becoming a part of the standard of care treatment for both newly diagnosed & recurrent GBM patients. $NWBO is closer to getting regulatory approvals in the US, Canada, UK, Germany & the rest of the EU.
RT @Dave46217976: #DCVAX $NWBO
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @Dave46217976: #DCVAX $NWBO
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @Dave46217976: #DCVAX $NWBO
#DCVAX $NWBO
RT @StevenBremMD: The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) c…
RT @KauriCapital: @joerogan #cancer #vaccine 😎💪Lifespan announce amazing results of cancer vaccine trial for aggressive brain cancer https:…
The complexity, heterogeneity of the overlapping pathways (redundancy) as well as the mutational drift (oncoplasticity) contribute to glioblastomas being resistant to therapy. Excited that the #dendritic cell vaccine could be part of the future solution. h
@dustinduckworth Encouraging. Glioblastomas are nasty, nasty. Surgery, radiation, chemo and still 5% 5 yr survival. Harnessing our amazing immune system is the most encouraging trend in all of cancer research. Here is the actual study published in JAMA.
@statnews
@joerogan #cancer #vaccine 😎💪Lifespan announce amazing results of cancer vaccine trial for aggressive brain cancer https://t.co/9l4dBWc3sA via @YouTube $NWBO https://t.co/Ji7W5ACPjJ https://t.co/xla0KCGa6z https://t.co/sYrrpkLFhl
RT @rago_carlo: @nytimes @WSJ @Forbes articles could help raise significant awareness of these promising cancer vaccine results. $NWBO
@joerogan #cancer vaccine 😎💪Lifespan to announce results of vaccine trial for aggressive brain cancer https://t.co/yoBsCzFvoN via @YouTube https://t.co/Ji7W5ACPjJ https://t.co/xla0KCGa6z https://t.co/sYrrpkLFhl
RT @double_whammied: News we can use!
RT @albtur_mnymkrs: @double_whammied @lobbccanada I’m happy to share with you news of a P3 human clinical trial that showed increased survi…
RT @double_whammied: News we can use!
RT @albtur_mnymkrs: @double_whammied @lobbccanada I’m happy to share with you news of a P3 human clinical trial that showed increased survi…
News we can use!
@double_whammied @lobbccanada I’m happy to share with you news of a P3 human clinical trial that showed increased survival (a first in 20 years) for glioblastoma. It’s an immunotherapy treatment called #dcvax from $nwbo. Recently published in @JAMAOnc ht
RT @rago_carlo: @nytimes @WSJ @Forbes articles could help raise significant awareness of these promising cancer vaccine results. $NWBO
RT @rago_carlo: @nytimes @WSJ @Forbes articles could help raise significant awareness of these promising cancer vaccine results. $NWBO
@andrewpannu One of them will buy $NWBO https://t.co/Ji7W5ADn9h
RT @Ali_boy_180: . . ********** DCVax-L Success against GBM as per JAMA ************ . . #DCVax-L #GBM #Glioblastoma #murcidence…
RT @alphavestcap: https://t.co/9iE2VJClDr $nwbo @alphavestcap
https://t.co/9iE2VJClDr $nwbo @alphavestcap
. . ********** DCVax-L Success against GBM as per JAMA ************ . . #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO #neuroscience #science #Neurosurgery #oncology #BrainCancer
RT @HenryMuney: The #DCVax-L Phase 3 trial used "contemporaneous external controls", NOT "historical controls". There is a difference. Misi…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
@jason_willz1 No the issue is that you won't accept it. That's how this narrative works. https://t.co/AmXyyb32rO https://t.co/xuHLbUItHL
$nwbo ❤️ Happy new year!
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
RT @Arhdan9: @megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the…
@megtirrell @CNBC $NWBO $XBI $IBB Congrats! Well $NWBO is the biotech story in 2022 in people's heart, despite missing in the US media. It will be the biotech story of 2023 & beyond. https://t.co/Ji6ltP29NJ https://t.co/eW9NBZPEY8 https://t.co/U0Rj4aB
RT @ThomasOwenMcCa1: Hey, @jonnajarian & @petenajarian worth a read… https://t.co/MPH5yW81fX
Hey, @jonnajarian & @petenajarian worth a read… https://t.co/MPH5yW81fX
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…